Does Moderate Physical Activity in Hemodialysis Patients Reduce Inflammation?

Martin-Luther-Universität Halle-Wittenberg

Status: Completed

Conditions: Hemodialysis; End-stage Renal Disease

Treatments: Behavioral: moderate physical activity

Study type: Observational

Funder types: Other

Identifiers

NCT00893165

KfH 2009-0010

KIM2H-2009-01

Roux 19/39

Details and patient eligibility

About

The purpose of this study is to observe a potential benefit of moderate physical activity by using bed mounted cycles during hemodialysis treatment sessions on inflammatory markers in the blood of patients with end-stage renal disease (ESRD).

Full description

Patients with ESRD on chronic hemodialysis patients frequently have elevated markers of inflammation (e.g., serum CRP values) and accumulation of proinflammatory monocyte populations in the circulation. The level of inflammation is highly predictive for cardiovascular disease and mortality. Physical activity has been shown to improve dialysis efficacy by improving the elimination of retention solutes. In healthy individuals, sports activity influences inflammatory immune parameters. The study will observe the influence of moderate physical activity (using a bed mounted cycle for 30min during dialysis thrice weekly) on circulating monocyte subpopulations and inflammatory proteins over a 9 month period in 16 chronic hemodialysis patients.

Enrollment: 16 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• chronic hemodialysis treatment for at least three months
• three dialysis sessions per week
• good general clinical condition
• stable hemodynamics during the most recent three dialysis sessions

Exclusion criteria

• conditions making the patient unable to use the bed mounted cycle (amputations, joint disease etc)
• clinically obvious acute infections
• active malignancy
• pathologic results of spiroergometry or echocardiography that imply an elevated risk of participation
• myocardial infarction within the last 12 weeks
• uncontrolled arterial hypertension
• uncontrolled diabetes mellitis with frequent hypoglycemia
• unability to understand and consent the protocol

Trial design

16 participants in 1 patient group

hemodialysis patients

Description:

chronic hemodialysis patients with elevated inflammation markers

Treatment:

Behavioral: moderate physical activity